MAPLEX – a photoinducible protein delivery system from engineered exosomes

Delivering therapeutic proteins directly into cells is a promising approach for treating a variety of diseases. However, this task is complicated by the challenge of getting these proteins across the cell membrane effectively. A groundbreaking study by researchers at Sungkyunkwan University has explored the use of exosomes—tiny vesicles naturally secreted by cells—as carriers for these therapeutic proteins.

What Are Exosomes?

Exosomes are small, membrane-bound vesicles that transport molecules between cells. Due to their natural origin and ability to cross cell membranes, they are considered excellent candidates for delivering therapeutic agents directly into cells.

The New Approach: MAPLEX

The researchers have developed an innovative system called MAPLEX, which stands for mMaple3-mediated Protein Loading into and Release from Exosome. This system uses exosomes to deliver proteins inside cells, but with a special twist: the proteins are loaded into the exosomes in a way that allows them to be released on demand.

Here’s how it works:

1. Loading: Proteins are attached to a light-sensitive molecule (mMaple3) that is linked to exosome membrane markers. This allows the proteins to be incorporated into the exosomes.
2. Release: Once inside the target cells, the proteins can be released from the exosomes by shining blue light on them. This light triggers a reaction that causes the proteins to detach from the exosome membrane and enter the cell.

Key Applications

1. Gene Regulation: In laboratory tests, MAPLEX was used to deliver specific transcription factors to cells, leading to changes in gene activity.
2. Gene Recombination: In genetically modified mice, MAPLEX successfully delivered Cre recombinase, a protein that can modify DNA sequences, demonstrating its potential for genetic engineering.
3. Alzheimer’s Disease: In mouse models of Alzheimer’s, MAPLEX delivered a protein complex designed to alter DNA methylation patterns in the brain. This intervention reduced the expression of a gene associated with Alzheimer’s and improved memory and brain health.

Conclusion

The MAPLEX system represents a significant advancement in protein delivery technology. By using exosomes as carriers and incorporating a light-triggered release mechanism, this approach offers a versatile and efficient way to deliver a range of therapeutic proteins. This technology could pave the way for new treatments for various diseases, including neurodegenerative conditions like Alzheimer’s, by enabling precise and controlled delivery of therapeutic agents.